Cytori Cell Research Institute, Inc. (3750.T)
JPY 666.0
(0.3%)
JPY 666.0
(0.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 103.53 Million JPY | -10.91% |
| 2022 | 116.21 Million JPY | -92.94% |
| 2021 | 1.64 Billion JPY | -67.27% |
| 2020 | 5.02 Billion JPY | -6.33% |
| 2019 | 5.36 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 110 Million JPY | 6.25% |
| 2023 Q3 | 140.66 Million JPY | -17.75% |
| 2023 FY | 103.53 Million JPY | -10.91% |
| 2023 Q4 | 103.53 Million JPY | -26.4% |
| 2023 Q2 | 171.01 Million JPY | 47.03% |
| 2023 Q1 | 116.31 Million JPY | 0.09% |
| 2022 Q3 | 154 Million JPY | -16.39% |
| 2022 Q2 | 184.19 Million JPY | 0.0% |
| 2022 Q4 | 116.21 Million JPY | -24.54% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 84.842% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -477.467% |
| GNI Group Ltd. | 2.33 Billion JPY | 95.558% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 95.352% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -53.427% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 90.763% |
| AnGes, Inc. | 1.61 Billion JPY | 93.592% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -39.913% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 96.434% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 67.838% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -56168.478% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 26.121% |
| CanBas Co., Ltd. | 728 Thousand JPY | -14121.703% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -17.836% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 30.016% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -61.502% |
| Kidswell Bio Corporation | 875.65 Million JPY | 88.176% |
| PeptiDream Inc. | 2.4 Billion JPY | 95.694% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -1838.113% |
| Ribomic Inc. | 2.27 Million JPY | -4452.946% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -10353399900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -187.594% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -257.014% |
| CellSource Co., Ltd. | 305.92 Million JPY | 66.157% |
| FunPep Company Limited | 25.54 Million JPY | -305.364% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 71.561% |
| Stella Pharma Corporation | 1.11 Billion JPY | 90.725% |
| TMS Co., Ltd. | 50.02 Million JPY | -106.965% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -395.354% |
| Cuorips Inc. | 1.04 Million JPY | -9826.558% |
| K Pharma,Inc. | 10.79 Million JPY | -859.181% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.126% |
| ReproCELL Incorporated | 248.14 Million JPY | 58.276% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 77.022% |
| StemCell Institute Inc. | 42.26 Million JPY | -144.981% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 54.703% |
| CellSeed Inc. | 46.19 Million JPY | -124.143% |